Touchstone International Medical Science Co Ltd Asset Resilience Ratio
Touchstone International Medical Science Co Ltd asset resilience ratio. Touchstone International Medical Science Co Ltd (688013) has an Asset Resilience Ratio of 37.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Touchstone International Medical Science fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Touchstone International Medical Science Co Ltd (2020–2024)
Asset resilience ratio of Touchstone International Medical Science Co Ltd from 2020 to 2024. This chart shows how Touchstone International Medical Science Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Touchstone International Medical Science for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Touchstone International Medical Science Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Touchstone International Medical Science asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥255.91 Million | 37.86% |
| Total Liquid Assets | CN¥255.91 Million | 37.86% |
Asset Resilience Insights
- Very High Liquidity: Touchstone International Medical Science Co Ltd maintains exceptional liquid asset reserves at 37.86% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Touchstone International Medical Science Co Ltd Industry Peers by Asset Resilience Ratio
Compare Touchstone International Medical Science Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Imeik Technology Development Co
SHE:300896 |
Medical Instruments & Supplies | 26.02% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 6.42% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
Touchstone International Medical Science Co Ltd Asset Resilience Ratio by Year (2020–2024)
Touchstone International Medical Science Co Ltd asset resilience ratio by year from 2020 to 2024. The table below shows the annual Asset Resilience Ratio data for Touchstone International Medical Science Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 51.94% | CN¥331.00 Million ≈ $48.44 Million |
CN¥637.24 Million ≈ $93.25 Million |
+17.07pp |
| 2023-12-31 | 34.87% | CN¥218.52 Million ≈ $31.98 Million |
CN¥626.61 Million ≈ $91.69 Million |
-25.72pp |
| 2022-12-31 | 60.59% | CN¥329.28 Million ≈ $48.18 Million |
CN¥543.46 Million ≈ $79.52 Million |
-4.66pp |
| 2021-12-31 | 65.25% | CN¥355.49 Million ≈ $52.02 Million |
CN¥544.83 Million ≈ $79.73 Million |
+13.20pp |
| 2020-12-31 | 52.05% | CN¥252.56 Million ≈ $36.96 Million |
CN¥485.24 Million ≈ $71.01 Million |
-- |
About Touchstone International Medical Science Co Ltd
Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and re… Read more